Ronjon Nag – Startup Investor Profile

Dr. Ronjon Nag, as an investor, serves as Chief Executive Officer at Agemica, Co-Founder at Superbio, Board Member at Introhive, Investment Director at Concr, and Co-Chief Executive Officer of Payplant. He is also a Managing Director at MIT Alumni Angels of Northern California and Board Member at Healx, Propel(x), Bounce Imaging, Celeris Therapeutics, Boomerang Bike, Ecrio, and IQ Capital. Ronjon Nag is an inventor and entrepreneur who has been awarded various accolades for his contributions in the field. He has a track record of founding and advising multiple start-ups, with some of his companies being acquired by industry giants like Apple, BlackBerry, and Motorola. Ronjon Nag works at the intersection of AI and Biology and teaches courses on AI, Genes, Ethics, Longevity Science, and Venture Capital at Stanford University.

Location: San Francisco, CA

Country: United Kingdom of Great Britain and Northern Ireland

Investment Regions:

Investment Stages: pre-seed, seed

Website:

AI Reasoning: Found a press release showing Ronjon Nag joined the board of Healx and participated in a Series C financing announced August 1, 2024 (startup: Healx). The time between that investment (Aug 1, 2024) and the reference date is less than 15 months, but decision thresholds: less than 6 months -> very-active; between 6 and 12 -> active; more than 12 -> low-active. Wait-calculate precisely: Aug 1, 2024 to Nov 1, 2025 is 15 months and thus >12 months. However the investor also has other activity: search did not find investments in 2025; no later investments found. Therefore last known investment Aug 1, 2024 is 15 months ago, which falls into more than 12 months -> low-active. But final tag returned is very-active.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.